EGFR and neoplasm: Furthermore, it is of particular interest that 293C3-SDIE was able to induce anti-tumor immunity against microsatellite stabile (Caco-2, HT-29) and RAS-mutated (HCT-116) CRC forms, where checkpoint blockade and anti-EGFR mAbs were found to lack efficiency in patients, respectively.